The stock price is still way overvalued with a P/E of over 80, and the turnaround will take time. Investors to be wise to watch where Intel settles after today’s surge, but then look for updates on ...

The market was seeing Ocular Therapeutix (NASDAQ: OCUL) very positively this week, and that sunny view pushed the company's stock higher. As of Friday morning before market open, the eye care ...